Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ELLA-CS is a Czech medical device company focused on the research, development, manufacture, and global commercialization of gastrointestinal and related specialty stents. The company is best known for its biodegradable esophageal stent, the Danis stent for control of acute variceal bleeding, and a portfolio of CE-marked esophageal, biliary, pyloroduodenal, and colorectal stents, including customized devices. Beyond its own products, ELLA-CS offers OEM and contract manufacturing services for medical devices, with capabilities spanning metal processing, coating, assembly, packaging, sterilization, and testing. The business exports most of its production internationally and positions itself as a global specialist in biodegradable stent technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ELLA-CS.